AZN logo

AstraZeneca (AZN)

Profile

Full Name

AstraZeneca PLC

Ticker Symbol

NASDAQ: AZN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United Kingdom

IPO

May 12, 1993

Indexes

NASDAQ 100

Website

http://www.astrazeneca.com

Employees

94300

Key Details

Price

$69.45(-2.36%)

Market cap

$215.32B(Mega cap)

Last Dividend

$1.05

TTM Dividend yield

2.23%

Annual revenue

$54.07B(+18.03% YoY)

Annual EPS

$2.25(+18.11% YoY)

PE ratio

27.89

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $69.45
    AZN price is $69.45

    30-Day Relative Volume

    1.62
    AZN 30-day relative volume is 1.62

    Price Performance

    Price Most recent change

    -2.36%
    AZN price was down -2.36% on Jul 3, 2025

    Price YTD change

    +6%
    AZN price is up +6% since January 1st

    Price 1-year change

    -9.57%
    AZN price is down -9.57% year-on-year

    Price 3-year change

    +5.31%
    AZN price is up +5.31% over the past 3 years

    Price Range

    Price All-time high

    $87.68
    AZN price is currently -20.79% below its historical high of $87.68

    Price 3-year low

    $52.65
    AZN price is currently +31.91% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $215.32B
    AZN market capitalization is $215.32 billion

    Market cap 3-year change

    +5.36%
    AZN market capitalization is up +5.36% over the past 3 years

    Market cap All-time high

    $271.67B
    AZN market capitalization is currently -20.74% below its historical high of $271.67 billion

    Market cap sector rank

    99.43%
    AZN market capitalization is higher than 99.43% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    AZN {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +0.05%
    AZN shares outstanding is up +0.05% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.36
    AZN beta is 0.36

    200-day SMA

    $71.18
    AZN price is currently -2.43% below its 200-day simple moving average

    50-day SMA

    $70.71
    AZN price is currently -1.78% below its 50-day simple moving average

    RSI

    42.43
    AZN 14-day relative strength index is 42.43

    Volume

    1.62
    AZN 30-day relative volume is 1.62

    ATR

    $1.30
    AZN average true range is $1.30

    10-day Historical Volatility

    20.34%
    AZN 10-day historical volatility is 20.34%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.05
    AZN last dividend was $1.05 per share, with an ex-dividend date of February 21, 2025

    Next Dividend

    -
    AZN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.49
    AZN annual dividend per share is $1.49

    Dividend per share Sector Rank

    56.47%
    AZN annual dividend per share is higher than 56.47% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +2.41%
    AZN annual dividend per share is up +2.41% year-on-year

    Dividend per share 3-Year Change

    +6.07%
    AZN annual dividend per share is up +6.07% over the past 3 years

    Dividend yield

    Dividend yield

    2.14%
    AZN annual dividend yield is 2.14%

    Dividend yield Sector Rank

    54.76%
    AZN annual dividend yield is higher than 54.76% of companies in Healthcare sector

    Other

    Payout ratio

    65.80%
    AZN annual payout ratio is 65.80%

    Dividends paid

    $4.63B
    AZN annual dividends paid is $4.63 billion

    Free cash flow

    $7.28B
    AZN annual free cash flow is $7.28 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $54.07B
    AZN annual revenue is $54.07 billion

    Revenue Analysts estimate

    $57.83B
    AZN annual revenue is currently -6.50% lower than the consensus analysts' forecast

    Revenue 1-year change

    +18.03%
    AZN annual revenue is up +18.03% year-on-year

    Revenue Sector rank

    98.3%
    AZN annual revenue is higher than 98.3% of companies in Healthcare sector

    EPS

    EPS

    $2.25
    AZN annual earnings per share is $2.25

    EPS Analysts estimate

    $4.51
    AZN annual earnings per share is currently -50.07% lower than the consensus analysts' forecast

    EPS 1-year change

    +18.11%
    AZN annual earnings per share is up +18.11% year-on-year

    EPS Sector rank

    92.75%
    AZN annual earnings per share is higher than 92.75% of companies in Healthcare sector

    Profit

    Gross profit

    $43.87B
    AZN annual gross profit is $43.87 billion

    Gross margin

    81.12%
    AZN annual gross profit margin is 81.12%

    Operating profit

    $10.00B
    AZN annual operating income is $10.00 billion

    Operating margin

    18.50%
    AZN annual operating profit margin is 18.50%

    Net income

    $7.04B
    AZN annual net profit is $7.04 billion

    Net margin

    13.01%
    AZN annual net profit margin is 13.01%

    Expenses

    Total expenses

    $44.07B
    AZN annual total expenses is $44.07 billion

    Operating expenses

    $33.86B
    AZN annual total operating expenses is $33.86 billion

    Cost of goods sold

    $10.21B
    AZN annual cost of goods sold is $10.21 billion

    Selling, general & administrative expenses

    $20.53B
    AZN annual SGA is $20.53 billion

    Depreciation and amortization

    $6.69B
    AZN annual depreciation & amortization is $6.69 billion

    Interest expense

    $1.68B
    AZN annual interest expense is $1.68 billion

    Income tax

    $1.65B
    AZN annual income tax is $1.65 billion

    EBIT & EBITDA

    EBIT

    $10.43B
    AZN annual earnings before interest & taxes is $10.43 billion

    EBITDA

    $17.12B
    AZN annual EBITDA is $17.12 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $104.03B
    AZN annual total assets is $104.03 billion

    Non current assets

    $78.21B
    AZN annual long term assets is $78.21 billion

    Current assets

    $25.83B
    AZN annual total current assets is $25.83 billion

    Cash and cash equivalents

    $5.49B
    AZN annual cash & cash equivalents is $5.49 billion

    Accounts receivable

    $8.30B
    AZN annual accounts receivable is $8.30 billion

    Inventory

    $5.29B
    AZN annual inventory is $5.29 billion

    Liabilities

    Total liabilities

    $63.16B
    AZN annual total liabilities is $63.16 billion

    Long term liabilities

    $35.30B
    AZN annual total long term liabilities is $35.30 billion

    Current liabilities

    $27.87B
    AZN annual total current liabilities is $27.87 billion

    Accounts payable

    $3.64B
    AZN annual accounts payable is $3.64 billion

    Debt

    Total debt

    $30.30B
    AZN annual total debt is $30.30 billion

    Total debt 1-year change

    +5.85%
    AZN annual total debt is up +5.85% year-on-year

    Long term debt

    $27.62B
    AZN annual long term debt is $27.62 billion

    Short term debt

    $2.68B
    AZN annual short term debt is $2.68 billion

    Equity & Capital

    Shareholders equity

    $40.79B
    AZN annual stockholders equity is $40.79 billion

    Book value

    $40.79B
    AZN annual book value is $40.79 billion

    Retained earnings

    $3.16B
    AZN annual retained earnings is $3.16 billion

    Working capital

    -$2.04B
    AZN annual working capital is -$2.04 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $11.86B
    AZN annual cash flow from operations is $11.86 billion

    Cash from operations 1-year change

    +14.65%
    AZN annual cash flow from operations is up +14.65% year-on-year

    Cash from investing

    -$7.98B
    AZN annual cash flow from investing activities is -$7.98 billion

    Cash from investing 1-year change

    -96.36%
    AZN annual cash flow from investing activities is down -96.36% year-on-year

    Cash from financing

    -$4.00B
    AZN annual cash flow from financing activities is -$4.00 billion

    Cash from financing 1-year change

    +39.15%
    AZN annual cash flow from financing activities is up +39.15% year-on-year

    CAPEX

    CAPEX

    $4.59B
    AZN annual capital expenditures is $4.59 billion

    CAPEX 1-year change

    +21.39%
    AZN annual capital expenditures is up +21.39% year-on-year

    Free Cash Flow

    Free cash flow

    $7.28B
    AZN annual free cash flow is $7.28 billion

    Free cash flow 1-year change

    +10.78%
    AZN annual free cash flow is up +10.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    81.12%
    AZN annual gross profit margin is 81.12%

    Operating margin

    18.50%
    AZN annual operating profit margin is 18.50%

    Net margin

    13.01%
    AZN annual net profit margin is 13.01%

    ROA & ROE

    ROA

    6.86%
    AZN annual return on assets is 6.86%

    ROE

    17.58%
    AZN annual return on equity is 17.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    27.89
    AZN price to earnings ratio is 27.89

    PE ratio Sector rank

    57.01%
    AZN price to earnings ratio is higher than 57.01% of companies in Healthcare sector

    PB Ratio

    PB ratio

    5.25
    AZN price to book ratio is 5.25

    PB ratio Sector rank

    81.28%
    AZN price to book ratio is higher than 81.28% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.92
    AZN price to sales ratio is 3.92

    PS ratio Sector rank

    57.48%
    AZN price to sales ratio is higher than 57.48% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $241.39B
    AZN enterprise value is $241.39 billion

    Enterprise value Sector rank

    99.5%
    AZN enterprise value is higher than 99.5% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    15.03
    AZN EV/EBITDA is 15.03

    EV/EBITDA Sector rank

    88.73%
    AZN EV/EBITDA is higher than 88.73% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.93
    AZN annual current ratio is 0.93

    Quick ratio

    0.74
    AZN annual quick ratio is 0.74

    Leverage

    Debt to equity

    0.71
    AZN annual debt to equity ratio is 0.71

    Interest coverage ratio

    6.20
    AZN annual interest coverage ratio is 6.20

    Risk & Stability

    Piotroski F-Score

    9
    AZN piotroski f-score is 9

    Altman Z-Score

    2.92
    AZN altman z-score is 2.92

    Analyst ratings

    Recent major analysts updates

    Feb 13, 25 UBS
    Buy
    Nov 20, 24 UBS
    Neutral
    Sep 11, 24 Erste Group
    Buy
    Aug 12, 24 TD Cowen
    Buy
    May 30, 24 Goldman Sachs
    Buy
    May 30, 24 Argus Research
    Buy
    Apr 26, 24 BMO Capital
    Outperform
    Apr 16, 24 Deutsche Bank
    Hold
    Feb 12, 24 BMO Capital
    Outperform
    Feb 8, 24 Deutsche Bank
    Hold

    Institutional Ownership

    Screeners with AZN included

    High Piotroski score stocks
    UK stocks
    Stocks below SMA 200
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    Mega cap stocks
    • What is the ticker symbol for AstraZeneca?
    • Does AstraZeneca pay dividends?
    • What sector is AstraZeneca in?
    • What industry is AstraZeneca in?
    • What country is AstraZeneca based in?
    • When did AstraZeneca go public?
    • Is AstraZeneca in the S&P 500?
    • Is AstraZeneca in the NASDAQ 100?
    • Is AstraZeneca in the Dow Jones?
    • When was AstraZeneca's last earnings report?
    • When does AstraZeneca report earnings?

    What is the ticker symbol for AstraZeneca?

    The ticker symbol for AstraZeneca is NASDAQ:AZN

    Does AstraZeneca pay dividends?

    Yes, AstraZeneca pays dividends. The last payment was $1.05, with an ex-dividend date on February 21, 2025

    What sector is AstraZeneca in?

    AstraZeneca is in the Healthcare sector

    What industry is AstraZeneca in?

    AstraZeneca is in the Drug Manufacturers - General industry

    What country is AstraZeneca based in?

    AstraZeneca is headquartered in United Kingdom

    When did AstraZeneca go public?

    AstraZeneca's initial public offering (IPO) was on May 12, 1993

    Is AstraZeneca in the S&P 500?

    No, AstraZeneca is not included in the S&P 500 index

    Is AstraZeneca in the NASDAQ 100?

    Yes, AstraZeneca is included in the NASDAQ 100 index

    Is AstraZeneca in the Dow Jones?

    No, AstraZeneca is not included in the Dow Jones index

    When was AstraZeneca's last earnings report?

    AstraZeneca's most recent earnings report was on April 29, 2025

    When does AstraZeneca report earnings?

    The next expected earnings date for AstraZeneca is July 29, 2025
    On this page